title: Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
abstract: Prognosis after allogeneic hematopoietic stem cell transplantation (HSCT) has greatly improved. Therefore, long-term survivorship becomes an important issue. A number of malignant and nonmalignant late effects can cause substantial morbidity, with considerable impact on health and quality of life. The main factors responsible for late effects after HSCT are total body irradiation-based conditioning and chronic graft-versus-host disease and its treatment. The knowledge on late effects serves as guidance for surveillance and management decision. Aftercare includes screening and counseling for prevention and treatment of late complications. The care of HSCT recipients tends with time to be transferred from the transplant center back to the primary care provider, who might not be however familiar with the unique needs of long-term survivors. A broad expertise is needed for the post-transplant management; therefore, transplant centers together with primary care providers should ensure complementary care delivery. Standardized follow-up guidelines on late effects represent the best tool to guaranty good management of long-term survivors. Distribution, broad promotion, and applications of these guidelines are therefore needed.
authors: Division of Hematology, University Hospital of Basel, Petersgraben 4, 4031, Basel, Switzerland, tichelli@datacomm.ch.
authors: André
authors: A
authors: Tichelli
authors: Alicia
authors: A
authors: Rovó
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology; D019468:Disease Management; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D008134:Long-Term Care / Q000379:methods; D011320:Primary Health Care / Q000379:methods*; D011788:Quality of Life; D012307:Risk Factors; D015996:Survival Rate; D017741:Survivors; D019172:Transplantation Conditioning / Q000009:adverse effects; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation / Q000009:adverse effects